EMA updates the PRIME pathway with roadmaps :
• To improve its PRIority MEdicines (PRIME) program, which aims to hasten the development of medicines for unmet needs, the European Medicines Agency (EMA) has taken recommendations from a recent report. The modifications include making sure that drug sponsors and regulators agree on the process and deadlines for getting the medicine through review.
• In order to give businesses creating medications for unmet medical needs more opportunity to interact with regulators, EMA introduced the pathway in 2016.
• The roadmap and tracker will take the role of the PRIME yearly update beginning in March 2023 as a pilot program for any items that have not previously been covered in a Kick-off meeting.
fore more https://www.novumprs.com/ema-updates-the-prime-pathway-with-roadmaps/